Main Catalog

Found 73

Sort by

Member Free

Non-Member $30.00

2019-2020 Pharmaceutical Marketplace Trends

Not Accredited for CPE: This online program will provide an up-to-the-minute analysis of the pharmaceutical market and offer predictions about what lies ahead in the coming months as the health care industry manages the COVID-19 pandemic.

AMCP eLearning Days 2019-2020 Trends

Member Free

Non-Member $30.00

A Path Forward: Medicaid Accountable Care Organization Implementation

Contact Hours: 1.5. While a dozen states have implemented new Accountable Care Organization (ACO) Medicaid models, another 12 are in the planning phases.

Accountable Care Organization

Member Free

Non-Member $30.00

A State Medicaid’s Experience Implementing an Oversight Program for Behavioral Health Medications in Publicly Insured Youth

Contact Hours: 1.5. Utilization of behavioral health medications in the pediatric population has increased in recent years, a trend that has generated major concern given the limited supporting evidence.

Patient Care

Member Free

Non-Member $30.00

AMCP Federal and State Legislative/Regulatory Update Home Study 2020

Contact Hours: 1.0. In today’s world, healthcare legislation and regulation move at a staggering pace making it difficult for health professionals to keep up.

Law

Member Free

Non-Member $30.00

AMCP Headline Session: 2017–2018 Pharmaceutical Marketplace Trends

Not Accredited for CPE: Keeping abreast of industry trends and forecasts is vital to remaining competitive in the evolving managed care arena— especially because market predictions can shape the approach to managing the pharmacy benefit.

AMCP Headline Session 2018

Member Free

Non-Member $30.00

Best Practices to Implementing Proactive Communications Between Manufacturers and Payers

Contact Hours: 1.25. The recent enactment of the 21st Century Cures Act, and specifically Section 3037 (Cures 3037), modernized provisions of the Food and Drug Administration Modernization Act of 1997, Section 114 (FDAMA 114).

Managed Care Regulation

Member Free

Non-Member $30.00

Biosimilars in the United States: Barriers, Solutions, Real-World Evidence, and the Experience of One Health System

Contact Hours: 1.5. As of July 2019, the U.S. Food and Drug Administration (FDA) had approved 25 biosimilar or follow-on biologic products.

Biosimilars

Member Free

Non-Member $30.00

Brand and Generic Drugs in Development

Contact Hours: 1.25. This session focuses on new and emerging brand-name drugs, as well as upcoming generic drug approvals.

Brand and Generic Drugs

Member Free

Non-Member $30.00

Cannabis Use in Health Care: What Payers Need to Know Home Study

Contact Hours: 1 - Despite a lack of regulatory and legal clarity, significant numbers of patients in Medicare, Medicaid, CHIP, and commercial plans currently use medical cannabis.

AMCP eLearning Days Cannabis

Member Free

Non-Member $30.00

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers, and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).

Health Care Reform

Member Free

Non-Member $30.00

Coverage and Reimbursement for High-Cost Curative Therapeutics: Does a Solution Exist? - Nexus 2018

Contact Hours: 1.5. More and more, managed care organizations are straddling the line between making new, innovative therapies available to their patients and ensuring they can cover the costs of these therapies.

Drug Pricing

Member Free

Non-Member $30.00

Developing Professional Strategies to Enhance Digital Engagement

Not Accredited for CPE: 2020 will no doubt be the year of digital engagement. On this webinar, Digital Marketing Strategist Eddie Bradley will share tips and insights on how subject matter experts and industry leading brands are leveraging content to grow and further engage with their audience.

Digital Engagement AMCP eLearning Days

Member $15.00

Non-Member $30.00

Developments, Research, Pipeline, and Applications of Gene Therapy - Annual 2019

Contact Hours: 0.75: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.

Gene Therapy

Member Free

Non-Member $30.00

Digital Therapeutics: Understanding the Emerging Product Class Home Study

Contact Hours: 1 - Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.

Digital Health AMCP eLearning Days

Member Free

Non-Member $30.00

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars Home Study

Contact Hours: 1 - This session focuses on new and emerging traditional pharmaceutical brand-name drugs, as well as upcoming generic and biosimilar drug approvals.

Drug Pipeline AMCP eLearning Days

Member Free

Non-Member $30.00

End of an Era: Lessons Learned from 2018 CMS Audits, and Prep for the Future - Nexus 2018

Contact Hours: 1.5. Ready for that upcoming 2019 audit? Do you know how to prepare? If your answer is no, join this session to hear how health plans prepare for their audits and address corrective actions, as lessons learned from the 2018 audit season are discussed.

CMS

Member Free

Non-Member $30.00

Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes Home Study

Contact Hours: 1 - Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools.

Digital Health AMCP eLearning Days

Member Free

Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ - Home Study

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.

Digital Health

Member Free

Non-Member $30.00

Experience and Lessons Learned in Biosimilar Uptake - Nexus 2018

Contact Hours: 1.5. Although biosimilars have been on the market for some time, payers continue to face many challenges in implementation.

Biosimilars

Member Free

Non-Member $30.00

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.

Specialty Drug Spend

Member Free

Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2018

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to pharmacists and other managed care and specialty pharmacy professionals.

Law

Member Free

Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2019

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.

Law

Member Free

Non-Member $30.00

Federal and State Legislative and Regulatory Update - Nexus 2018

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.

Law

Member $15.00

Non-Member $30.00

Financial Models to Manage Drug Spend of Gene Therapy - Annual Meeting 2019

Contact Hours 1 - Gene therapy techniques offer potential breakthroughs for patients with serious health conditions. They also are associated with significant short-term costs yet hold the promise of long-term savings.

Gene Therapy

Member $399.00

Non-Member $499.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 - The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member $199.00

Non-Member $249.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

Not Accredited for CPE: The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member $15.00

Non-Member $30.00

Gene Therapy for Hemophilia: Hope for a Cure? - Annual Meeting 2018

Contact Hours: 0.75. The best currently available treatments for hemophilia reduce but do not eliminate the possibility of bleeding.

Hemophilia

Member Free

Non-Member $30.00

Getting Up to Speed on Prescription Drug Pricing Reform Efforts Home Study

Contact Hours: 1 - Prescription drug pricing reform is a high-profile issue heading into the 2020 elections. President Trump, members of Congress, and the Democratic presidential candidates.

AMCP eLearning Days Drug Pricing

Member Free

Non-Member $69.00

Health Care Trends and the Impact of COVID-19

Not Accredited for CPE: The COVID-19 global pandemic has had a tremendous impact on the health care community. As the pandemic continues, it is vital to remain informed on how it has affected overall health care trends and, specifically, how those trends have impacted managed care pharmacy.

Covid-19

Member Free

Non-Member $30.00

Health Policy Trends Impacting Managed Care Pharmacy: Are You Ready?

Not Accredited for CPE: Congress, the White House, and presidential candidates are proposing major health policy changes in an election year where health care is a top issue on voters’ minds.

Health Policy AMCP eLearning Days

Member Free

Non-Member $30.00

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.

Drug Shortages

Member Free

Non-Member $30.00

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.

Social Determinants

Member Free

Non-Member $30.00

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.

Value-Based Contracting

Member $15.00

Non-Member $30.00

Introduction to Gene Therapy: Key Terms, Concepts, and International Perspectives - Annual Meeting 2019

Contact Hours: 1 - Gene therapy is an investigational technique that offers exciting promise of curing many debilitating and potentially terminal diseases, such as cystic fibrosis, multiple sclerosis, hemophilia, sickle cell disease, and spinal muscular atrophy.

Gene Therapy

Member Free

Non-Member $30.00

It’s an ART: Formulary and Drug Use Management Strategies for HIV Medications - Annual 2019

Contact Hours: 1.25. As people with HIV age, the focus of disease management places more emphasis on the safety of long-term medication use and managing comorbidities. The advantages of safer, more efficacious medications also come with increased cost.

HIV

Member Free

Non-Member $30.00

Key Forces Driving Change in Oncology

Contact Hours: 1.25. Oncology practice is changing rapidly as new advances in innovation lead to new evidence and testing requirements, as well as treatment guidelines.

Oncology

Member $15.00

Non-Member $30.00

Managing Patients with Hemophilia: A Payer’s Perspective - Annual Meeting 2018

Contact Hours: 1 - Thanks to significant improvements in the treatment of hemophilia, patients are living longer than ever before, with higher expectations for
near-normal quality of life.

Hemophilia

Member Free

Non-Member $30.00

Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Contact Hours: 1.25: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.

Specialty

Member Free

Non-Member $30.00

Medical Oncology Drug Cost Trends and Innovative, Practical Payer Management Strategies - Nexus 2018

Contact Hours: 1.5. Medical oncology drugs represent 35 to 47% percent of total medical benefit drug spend.

Oncology

Member Free

Non-Member $30.00

Medicare Formulary Updates Impact

Contact Hours: 1.25. The Centers for Medicare and Medicaid (CMS) continues to critically evaluate formulary regulations and guidance to help lower drug costs.

Medicare

Member Free

Non-Member $30.00

More than Meets the Eye–Value-Based Contracts are More Prevalent than We Think

Contact Hours: 1.25. As the U.S. health care system evolves from a volume-driven system to one that rewards value, there is growing interest in value-based payment arrangements.

Value-Based Contracting

Member Free

Non-Member Free

Navigating Changes in Clostridioides difficile Prevention and Treatment - Home Study

Contact Hours: 1. 5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.

C. Diff

Member Free

Non-Member $30.00

Oncology: Investigating Trends and Elucidating Value - Home Study

Contact Hours: 1 - Cancer is one of the world’s most pressing health care challenges, with more than 14 million people receiving a cancer diagnosis each year.

Oncology AMCP eLearning Days

Member Free

Non-Member Free

Opioid Use Disorder: Emerging Best Practices for Payer and Clinician Management of Patient Care - Home Study

Contact Hours: 1 - Addressing opioid use disorder (OUD) is a top concern for public health improvement. It is important to keep up with current treatment options to optimally treat patients, and while treatments vary by patient.

Opioid

Member Free

Non-Member $30.00

Patient Review and Restriction Programs: Prescription Drug Monitoring Programs and the Need for Collaboration

Contact Hours: 1.25. Patient Review and Restriction (PRR) programs are commonly used by health plans in doctor’s offices to manage the excessive prescribing of controlled substances or services.

Hospital/Health Systems

Member $15.00

Non-Member $30.00

Perspectives in Gene Therapy Management - Annual Meeting 2019

Contact Hours: 1 - The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders.

Gene Therapy

Member $15.00

Non-Member $30.00

Perspectives in Hemophilia Management - Annual Meeting 2018

Contact Hours: 1 - The treatment of hemophilia has evolved from a one-size-fits-all approach to a highly individualized care approach, and it continues to become more
patient-centered and specific.

Hemophilia

Member Free

Non-Member $30.00

Placing Potential Cures Within Reach: Real-World Experience and Evolving Management Home Study

Contact Hours: 1 - A prominent health care payer and pharmacy benefit manager (PBM) will share their real-world experiences and learnings in managing innovative and expensive gene therapies.

AMCP eLearning Days Potential Cures

Member Free

Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.

Alzheimer's

Member Free

Non-Member $30.00

Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Contact Hours: 1.25. Patients with pulmonary arterial hypertension (PAH) currently have a 60% five-year survival outlook, which has been increasing since the 1980s when it was a 37% five-year outlook.

Pulmonary Arterial Hypertension

Main Catalog

Error